Last reviewed · How we verify

NCT06617143: MBCT

Effect of MBCT Applied to Asthma Patients on Anxiety, Depressıon and Dyspnea

Completed NA Last updated 27 August 2025
What this trial tests

NA trial testing mindfulness-based cognitive therapy in Asthma in 48 participants. Completed in 15 August 2025.

Timeline
1 April 2025
Primary endpoint
31 July 2025
15 August 2025

Quick facts

Lead sponsorArdahan University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment48
Start date1 April 2025
Primary completion31 July 2025
Estimated completion15 August 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ardahan University

Who can join

18 and older, any sex, with Asthma or Mindfulness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, short-term MBCT will be applied to asthmatic patients receiving hospital treatment and its effects on anxiety, depression and dyspnea will be determined. A quasi-experimental study was planned for this purpose.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of mindfulness-based cognitive therapy

Trials testing the same drug.

Other recruiting trials for Asthma

Currently open trials in the same condition.

Other Ardahan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06617143.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing